New imaging tools could accelerate Parkinson's drug development

Researchers have mapped how molecular imaging techniques can speed up testing of experimental Parkinson's treatments, potentially cutting development timelines and costs. The work bridges the gap between laboratory discovery and clinical trials, giving pharmaceutical companies and regulators better tools to assess whether new drugs actually work before expensive large-scale studies.

Originaltitel: Translational molecular imaging and drug development in Parkinson's disease